US 12,247,235 B2
Liquid formation comprising GH10 xylanase and GH62 arabinofuranosidase
Yi Cao, Beijing (CN); Yu Zhang, Beijing (CN); Bernardo Vidal, Jr., Wake Forest, NC (US); Randall Scott Deinhammer, Wake Forest, NC (US); Mary Ann Stringer, Soborg (DK); Ye Liu, Beijing (CN); Purna Venkatesh, Bangalore (DK); and Cui Liu, Beijing (CN)
Assigned to NOVOZYMES A/S, Bagsvaerd (DK)
Filed by NOVOZYMES A/S, Bagsvaerd (DK)
Filed on May 11, 2021, as Appl. No. 17/316,811.
Application 17/316,811 is a continuation of application No. 16/341,214, granted, now 11,180,786, previously published as PCT/CN2017/112865, filed on Nov. 24, 2017.
Claims priority of application No. PCT/CN2016/107281 (WO), filed on Nov. 25, 2016.
Prior Publication US 2021/0261996 A1, Aug. 26, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/20 (2006.01); A01H 5/10 (2018.01); C08B 30/04 (2006.01); C11B 1/02 (2006.01); C11B 1/10 (2006.01); C12N 9/24 (2006.01); C12N 9/42 (2006.01); C12P 19/02 (2006.01); C12P 19/04 (2006.01); C12P 19/14 (2006.01); C13K 1/06 (2006.01)
CPC C12P 19/04 (2013.01) [A01H 5/10 (2013.01); C08B 30/04 (2013.01); C11B 1/025 (2013.01); C11B 1/10 (2013.01); C12N 9/2402 (2013.01); C12N 9/2434 (2013.01); C12N 9/248 (2013.01); C12N 9/2482 (2013.01); C12P 19/02 (2013.01); C12P 19/14 (2013.01); C12Y 302/01008 (2013.01); C12Y 302/01055 (2013.01); C13K 1/06 (2013.01)] 6 Claims
 
1. A liquid formulation comprising:
i) an enzyme blend comprising a beta-glucosidase, a cellobiohydrolase, an endoglucanase, a GH62 arabinofuranosidase, and a GH10 xylanase, wherein the arabinofuranosidase is present in an amount of 0.1-50 mg arabinofuranosidase protein per kg substrate (ppm), and wherein the xylanase is present in an amount of 0.1-50 mg xylanase protein per kg substrate (ppm); and
ii) a formulating agent selected from the group consisting of a polyol, a salt, a sugar, and combinations thereof.